Literature DB >> 31364211

Role of BRD4 phosphorylation in the nucleus accumbens in relapse to cocaine-seeking behavior in mice.

Wei Guo1,2, Hailei Long2, Qian Bu2,3, Yinglan Zhao2, Hongbo Wang1, Jingwei Tian1, Xiaobo Cen2.   

Abstract

Cocaine addiction is a chronic relapsing brain disorder characterized by compulsive drug seeking. Preliminary study suggested that bromodomain-containing protein 4 (BRD4), an epigenetic reader protein, participates in cocaine-induced reward and neuroplasticity. However, the exact role of BRD4 in cocaine addiction, particularly cocaine relapse, remains elusive. In this study, we found that BRD4 phosphorylation in the nucleus accumbens (NAc) was closely related to the maintenance of cocaine reinforcement and relapse in different cocaine exposure paradigms. Cocaine significantly increased the binding of phosphorylated BRD4 (pBRD4) at the promoter of Gria2 and Bdnf genes in the NAc. (+)JQ1, a selective BRD4 inhibitor, markedly reduced the reinforcement and reinstatement of cocaine-seeking behaviors, which was accompanied by the decreased expressions of GRIA2 and BDNF. Furthermore, chromatin immunoprecipitation assay showed that (+)JQ1 clearly attenuated cocaine-enhanced binding of pBRD4 at the promotor of Gria2 and Bdnf genes. Blockade of casein kinase II significantly attenuated BRD4 phosphorylation and cocaine relapse-like behaviors, suggesting the important role of pBRD4 in modulating cocaine effect. Together, our findings suggest that BRD4 phosphorylation in the NAc modulates multiple addiction-related behaviors of cocaine and particularly relapse to cocaine-seeking behaviors. Inhibition of BRD4 activity may be a novel target against cocaine addiction and relapse.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  BRD4 phosphorylation; cocaine; relapse

Year:  2019        PMID: 31364211     DOI: 10.1111/adb.12808

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  7 in total

1.  Opposing Functions of BRD4 Isoforms in Breast Cancer.

Authors:  Shwu-Yuan Wu; Chien-Fei Lee; Hsien-Tsung Lai; Cheng-Tai Yu; Ji-Eun Lee; Hao Zuo; Sophia Y Tsai; Ming-Jer Tsai; Kai Ge; Yihong Wan; Cheng-Ming Chiang
Journal:  Mol Cell       Date:  2020-05-23       Impact factor: 17.970

2.  Domain-selective BET inhibition attenuates transcriptional and behavioral responses to cocaine.

Authors:  Mandakini B Singh; Christopher J Babigian; Gregory C Sartor
Journal:  Neuropharmacology       Date:  2022-03-18       Impact factor: 5.250

3.  JQ1 attenuates psychostimulant- but not opioid-induced conditioned place preference.

Authors:  C J Babigian; H J Wiedner; C Wahlestedt; G C Sartor
Journal:  Behav Brain Res       Date:  2021-10-28       Impact factor: 3.332

Review 4.  The Functions of BET Proteins in Gene Transcription of Biology and Diseases.

Authors:  Ka Lung Cheung; Claudia Kim; Ming-Ming Zhou
Journal:  Front Mol Biosci       Date:  2021-09-03

Review 5.  BET bromodomains as novel epigenetic targets for brain health and disease.

Authors:  Mandakini B Singh; Gregory C Sartor
Journal:  Neuropharmacology       Date:  2020-09-15       Impact factor: 5.250

Review 6.  Epigenetic Mechanisms in Drug Relapse.

Authors:  Craig T Werner; Rachel D Altshuler; Yavin Shaham; Xuan Li
Journal:  Biol Psychiatry       Date:  2020-08-14       Impact factor: 13.382

Review 7.  Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor.

Authors:  Na Liu; Rui Ling; Xiang Tang; Yunpeng Yu; Yuepeng Zhou; Deyu Chen
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.